News

Objective Capital’s David H. Crean Named 2017 Finalist for Thought Leader of the Year

San Diego, December 12, 2017 — Objective Capital Partners, a middle market M&A Advisory Firm located in Southern California, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors who heads its thriving life science and healthcare practice, has been selected as top five national finalist for the 2017 Thought Leader of the Year Award by The Alliance of Merger & Acquisition Advisors® (AM&AA). For more information on the Award and the Finalists, please visit http://www.amaaonline.com/thought-leader-of-the-year/ (more…)

Bio Buck$ Fast Forward: A Start-up’s Guide to Investment Banks

Objective Capital’s David H. Crean to Serve as Guest Panelist at LaunchBio Event, November 14, 2017

San Diego, November 9, 2017 — Objective Capital Partners, a middle market M&A Advisory Firm located in Southern California, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors who heads its thriving life science and healthcare practice, has been invited to speak as a guest panelist at LaunchBio Series Event for life science companies entitled BIO Buck$ Fast Forward: A Start-ups Guide to Investment Banks. Dr. Crean will be joined by Charlie Adams, Cantor Fitzgerald and Tony Grover, VP of Business Development at Banyan Biomarker. (more…)

SoCal Capital Summit on M&A Healthcare Trends & Opportunities

 

Objective Capital’s David H. Crean to be Guest Panelist at ACG Orange County’s CEO Signature Event on November 15, 2017

San Diego, November 6, 2017 — Objective Capital Partners, a middle-market M&A Advisory Firm located in Southern California, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors who heads its thriving life science and healthcare practice, will be a guest panelist speaker at ACG Orange County’s CEO Signature Event entitled SoCal Capital Summit on November 15, 2017.   Dr. Crean and the fellow panelists will address M&A Healthcare Trends and Opportunities.  He will be joined by Greg Cunniff, CFO, NVISION Eye Centers, and Steven Shill, Partner and National Healthcare Practice Leader at BDO. (more…)

Objective Capital Partners Wins Four Awards at Advisor of the Year 2017

SAN DIEGO (October 30, 2017) — Objective Capital Partners, a middle-market M&A Advisory Firm located in Southern California, is pleased to announce that it has been awarded four Advisor of the Year awards including Best Sell-side Representation by an Investment Banker for a transaction more than $25M. Objective Capital won the Advisor of the Year awards in the following categories:

  • Best Sell-side Representation by an Investment Banker more than $25M for its advisory of GunVault and Cannon Safe in its sale to MidOcean Partners;
  • Best Sell-side Representation by an Investment Banker less than $25M for its advisory of Troxel Helmets in its sale to Weaver Leather;
  • Special Situation Advisory for its advisory of Minimal Invasive Devices in its sale to Cagan McAfee Capital Partners;
  • Contribution related to Valuation for its advisory to the internal sale of an undisclosed business services company.

(more…)

Objective Capital Partners Announced as Finalist in Seven Categories for Advisor of the Year Awards

SAN DIEGO (October 23, 2017) — Objective Capital Partners, a middle market M&A Advisory Firm located in Southern California, is pleased to announce it has been selected as a finalist in seven categories for Advisor of the Year 2017. These awards acknowledge middle market mergers and acquisitions professionals who have significantly contributed to the successful sale, expansion or recapitalization of their clients’ companies in the San Diego region. (more…)

M&A Deal Represented by Objective Capital Partners Selected as Finalist by The M&A Advisor

Information Technology Deal of the Year Finalist

New York, NY and San Diego, CA- October 11, 2017 –  The M&A Advisor is pleased to announce that one of the deals represented by Objective Capital Partners, a middle-market investment banking firm located in Southern California, was selected as a Finalist in the category for Information Technology Deal of The Year for the 16th Annual M&A Advisor Awards.  Objective Capital Partners served as the exclusive financial advisor to an undisclosed digital healthcare company on its confidential sale to a large private equity-backed acquirer.  Two other advisers on the deal included Kirkland & Ellis LLP and Sheppard Mullin Richter & Hampton LLP.  This is the third time in as many years that a deal represented by the investment banking firm was selected as a Finalist by the M&A Advisor. (more…)

Channing Hamlet to Keynote “What’s Your Business Really Worth?”

San Diego, CA- October 4, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A, healthcare & life sciences and valuation advisory services, is pleased to announce that Channing, Hamlet, one of its Managing Directors, will serve as Keynote Speaker as part of the Million Dollar Curriculum on “What’s Your Business Really Worth?”. The program will be held on October 11, 2017 at Corporate Alliance Center, 9171 Towne Centre Drive, San Diego, CA 92122 from 8 AM- 12 PM. The event is sponsored and presented by Cade & Company. (more…)

NRC Health and Practicing Excellence Form Strategic Alliance

Objective Capital Partners Acted as Financial Advisor to Practicing Excellence

San Diego, CA- September 25, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A, healthcare & life sciences and valuation advisory services, is pleased to announce the successful closing of one of its advisory engagements with Practicing Excellence upon its strategic alliance with and investment from NRC Health. Practicing Excellence, the developer of an online skill-building platform, connects clinicians to practical, evidence-based, colleague-tested tools designed to enhance the delivery of patient care and improve the overall physician experience. (more…)

Cagan McAfee Capital Partners Teams with Myles Sherman to Acquire Minimally Invasive Devices

Objective Capital Partners Acted as Financial Advisor to MID

 San Diego, CA- August 21, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A, healthcare & life sciences and valuation advisory services, is pleased to announce the successful closing of one of its advisory engagements with Minimally Invasive Devices (MID), privately-held medical device and market leading laparoscopic surgery solutions company, upon its acquisition by Cagan McAfee Capital Partners and seasoned investor/operator, Myles Sherman of Austin, TX. Objective Capital Partners acted as financial advisors to MID. (more…)

Objective Capital Partners’ Trever Acers to Address Business Exit Strategies at September ACG San Diego Event

Managing Director to Discuss Exit Options for Business Owners and C-Level Executives

San Diego, CA- August 10, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, Trever Acers, will serve on a panel of experts at the September event of the Association for Corporate Growth San Diego (ACG San Diego). The event entitled, “What’s Your Exit Strategy”, will be held on September 19, 2017 from 7-9 AM at Lomas Santa Fe Country Club in Solana Beach, CA.  Business Owners and C-level executives are encouraged to attend a Private Company Forum (PCF) from 9-10 AM.   (more…)

ACG San Diego Elects Objective Capital Partners’ Crean to Its Board of Directors

Managing Director to Serve as Chair of Marketing Committee

San Diego, CA- August 1, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, David H. Crean, Ph.D., was elected to serve on the Board of Directors for the San Diego Chapter of the Association for Corporate Growth (ACG San Diego).  The Chapter also added Jay Robinson-Duff, VP, First American Trust to its Board.  Dr. Crean has been a member of ACG for the past two years and will lead the Chapter’s marketing efforts.  At Objective Capital Partners, he is responsible for the firm’s strategy targeted at companies in the Healthcare and Life Sciences sector including pharmaceutical, biotechnology, medical technology, medical device, supplies, manufacturing and life science tools/ diagnostic firms looking for M&A, partnering, strategic advisory and capital financing options. (more…)

Business Exit Planning, Getting a Business Ready for Sale and Building Business Value

Objective Capital Partners’ Trever Acers to Address
North County Estate Planning Council of San Diego on August 1, 2017

San Diego, CA- July 24, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, Trever Acers, will be a panel speaker at the North County Estate Planning Council of San Diego on Tuesday, August 1, 2017. Mr. Acers will address Building and Protecting Business Value to Maximize Realized Dollars and Achieving Transaction Readiness and will be joined by fellow panelists Bob Copeland of Sheppard Mullin and Keith Troutman of Squar Milner. The event will be held at Morgan Run Club & Resort, 5690 Cancha de Golf, Rancho Santa Fe, CA 92091 from 7-9 AM. The guest fee for non-members is $30 and members attend free of charge. (more…)

Important Considerations in the Sale of Your Clients Business

Objective Capital’s Channing Hamlet to present on

July 6, 2017 at Southern California Institute

San Diego, CA- June 26, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, Channing Hamlet, will be a panel speaker as part of Southern California Institute’s (SCI) Thursday Insights on July 6, 2017. Greg Banner of Asset Preservation Strategies, Inc.will join Mr. Hamlet in presenting Important Considerations in the Sale of Your Clients Business. In this session, Greg and Channing will cover a number of core concepts that advisors can use to advise clients at this critical juncture in their personal and business life.  Specifically, they will discuss methods to maximize sale price, assess the sale for fit with client’s objectives, and methods to maximize after-tax cash. (more…)

Objective Capital’s Dr. David Crean to Address Entrepreneurs on Due Diligence Issues

San Diego Startup Week — June 19th – 23rd, 2017

San Diego, CA- June 19, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle-market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, David H. Crean, Ph.D., will be a panel speaker as part of San Diego Startup Week on June 19-23, 2017 in San Diego, CA. Dr. Crean will address issues to consider on due diligence from an investment banker’s perspective on June 21, 2017. He will be joined by fellow panelists Jeremy Glaser, Attorney and Partner at Mintz Levin, Brent Grenado, General Partner at Sway Ventures, Patrick Henry, CEO at Quest Fusion, and Walt Tendler, CFO at Mission Venture. (more…)

Objective Capital’s Dr. David Crean to Judge Life Sciences Company Pitches at Start-Up Stadium 2017

Start-up and Emerging Companies to Present at BIO2017

San Diego, CA- June 12, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle-market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, David H. Crean, Ph.D., will serve as a Judge for company finalists during live presentations as part of BIO 2017 Start-Up Stadium on June 20-22, 2017 in San Diego, CA. As the world’s largest biotechnology event, the BIO International Convention provides several specialized opportunities geared towards start-up and emerging companies. The Start-Up Stadium was designed to provide start-up companies with the opportunity to engage key members of the investment community, venture philanthropy groups, and BIO attendees. (more…)

The Math Behind the Aftermath Driving a Private-Public Merger Transaction: Mast Therapeutics and Savara

Objective Capital’s Dr. David Crean to Moderate M&A

Panel Discussion for ACG San Diego on June 20, 2017

San Diego, CA- June 6, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, David H. Crean, Ph.D., will serve as Moderator for ACG San Diego’s Hot Topics in Life Sciences M&A, June 20, 2017 at Lomas Santa Fe Country Club, Solana Beach, CA from 7-9 AM.

(more…)

Objective Capital’s Dr. David Crean to Address International Bar Association’s 5th Annual World Life Sciences Conference in San Diego, CA

Panel Discussion on Life Sciences Transactions, Research Collaborations, and Licensing Models to be presented on June 17, 2017

San Diego, CA- May 31, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, David H. Crean, Ph.D., will serve as a panel member and address legal professionals at the 5th Annual World Life Sciences Conference, June 16–17, 2017 at the Westin San Diego Gaslamp Quarter, San Diego, CA. The conference is presented by the International Bar Association (IBA), a global voice for the legal profession. The event will feature dynamic roundtable sessions covering the hottest topics and the latest developments from across the different sectors of the Life Science Industry. (more…)

Global Health Solutions Retains Objective Capital Partners As Exclusive Advisor for Acquiring Strategic Partnerships

San Diego, CA, May 15, 2017 Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, has announced that it has been retained as exclusive advisor to Global Health Solutions, LLC, to assist the company in exploring strategic partnerships and licensing agreements for its diverse product portfolio and pipeline for wound care, infection, and skin care. The priority focus will be on seeking best in class commercialization partners for the Company’s 510K FDA-cleared Hexagen™ Wound Dressing, which addresses the pressing need for effective solutions in the chronic and advanced wound market(s).  Additional assets to be partnered include the FiltreX™ Adhesive Dressing and pipeline assets in dermatology, infection control, biologics, and aesthetics. (more…)

A Roundtable for Life Science Executives: Private Capital Raising

Join CohnReznick, Objective Capital Partners, Wilson Sonsini and an Exclusive Group of Life Science Executives for Engaging Discussion on May 17

San Diego, CA- April 18, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that they have teamed up with CohnReznick and Wilson Sonsini Goodrich & Rosati  to sponsor a  Roundtable discussion on Private Capital Raising for Life Science Companies on Wednesday, May 17, 2017.  The Roundtable discussion will take place from 7:30-9:00 am at Barney & Barney in San Diego, CA.  (more…)

ACG San Diego Private Capital Expo: Healthcare

Objective Capital’s David H. Crean to Lead Discussion on Healthcare Topics at March 23rd Event 

San Diego, CA- March 10, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors and Head of its Life Sciences and Healthcare practice, will lead a group of expert panelists at San Diego’s Association of Corporate Growth (ACG) 7th Annual Private Capital Expo on March 23, 2017 from 5:00-8:00 PM. The panel will address Overall Valuation & Activity Levels in Private Capital Markets as part of a breakout session on Healthcare and Life sciences. Additional panel discussions will explore activity in three other dynamic business sectors including Software & Technology, Action Sports, and Industrial & Manufacturing. (more…)

Objective Capital Opens Los Angeles Office

San Diego, CA- March 7, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that the firm has opened a Los Angeles office as part of Objective Capital’s continued commitment to serve its Los Angeles and Orange County clients. This new office will broaden Objective Capital’s footprint in the Southern California region and further support Objective Capital’s team members serving its Los Angeles and Orange County clients as the firm continues to grow. Channing Hamlet, Managing Director of Objective Capital, will serve as principal lead at the Los Angeles office. (more…)

David H. Crean to Address Current Capital Raising Issues and Strategies for Biotech Companies to the Association of Corporate Counsel Life Sciences Roundtable

 

San Diego, CA- February 3, 2017 – Objective Capital Partners, a leading M&A investment banking firm focused on transactions for companies with enterprise values up to $500 million, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors and Head of its Life Sciences and Healthcare practice, will be a guest panelist speaker at Association of Corporate Counsel (ACC) of San Diego on March 2, 2017 from 5:00-6:30 PM. Dr. Crean will be joined by fellow panelists Dennis Doucette, Partner, Corporate & Securities, Practice Group Leader for Procopio, and David Szekeres, Senior Vice President, Business Development, General Counsel and Corporate Secretary for Heron Therapeutics, Inc. The panel will address Current Capital Raising Issues and Strategies for Biotech Companies. The event will be held at the offices of Procopio, Cory, Hargreaves & Savitch LLP, 12544 High Bluff Drive, Suite 300, San Diego, CA 92130. (more…)

San Diego Venture Group (SDVG) Adds Trever Acers to Its Board of Directors

San Diego, CA- February 1, 2017 – Objective Capital Partners, a leading M&A investment banking firm focused on transactions for companies with enterprise values up to $500 million, is pleased to announce that Trever Acers, one of its Managing Directors, has been elected to serve on the Board of Directors for San Diego Venture Group (SDVG).  SDVG is a non-profit organization designed to bring together entrepreneurs, advisors and capital providers who are interested in new ventures and furthering individual companies, as well as San Diego’s overall innovation community. (more…)

Objective Capital Partners Strengthens Its Healthcare & Life Sciences Investment Banking Practice with the Addition of Jack J. Florio

San Diego, CA- January 18, 2017 – Objective Capital Partners, a leading M&A investment banking firm focused on transactions for companies with enterprise values up to $500 million, is pleased to welcome the addition of Jack J. Florio fueling its ability to secure and execute high quality deals in the healthcare & life sciences space.  Mr. Florio brings more 40 years’ of global life sciences experience in major pharmaceutical, biotechnology, medical devices and digital health companies.  He has held senior management roles in both small and large companies including CEO, Corporate Development and Business Development.  He will serve as Managing Director and help with execution of the firm’s investment banking activities in the healthcare & life science space alongside David H. Crean, Ph.D.. (more…)

Objective Capital Partners Trever Acers to Address Company Needs for Obtaining Capital at the CFO Leadership Council

San Diego, CA- January 14, 2017 – Objective Capital Partners, a leading M&A investment banking firm focused on transactions for companies with enterprise values up to $500 million, is pleased to announce that Trever Acers, one of its Managing Directors, will be a guest panelist speaker at the CFO Leadership Council on February 16, 2017 from 7:15-9:30 AM. Mr. Acers will be joined by fellow panelists Craig Dupper, Managing Partner at Solis Capital Partners, Michael Umansky, Partner at Sheppard Mullin Richter & Hampton LLP and Gordon Wiens,  Senior Vice President at Bank of America.  The panel discussion will be moderated by Daniel Bruckart, VP & Relationship Manager at Bank of America Merrill Lynch. The panel will address Obtaining Capital: Debt and Equity. The event will be held at the offices of KPMG, 4747 Executive Drive, San Diego CA 92121. (more…)